Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients

NCT02190864 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT02190864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02190864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients
Lead sponsor
University of Nebraska
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2013
Completion date
June 30, 2016
Enrollment
210 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

age, comorbid conditions, fact-toi scores, gender, particularly rural/urban residence